Abstract:Background: The development of drug resistance and the persistence of leukemia stem cells are major obstacles for the use of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML). The induction of autophagic death in tumor cells represents a new route for leukemia treatment. Our previous study showed that infection of CML cells with oncolytic viruses carrying the autophagy gene Beclin1 downregulated BCR/ABL protein expression and significantly increased the killing effect of the oncolytic viruses on CML cells via autophagy activation. However, the specific molecular mechanisms underlying the regulation of BCR/ABL and Beclin1-dependent CML cell killing remain unclear. Methods: A physical interaction between BCR/ABL and Beclin1 was characterized via GST-pulldown, co-IP and dual-luciferase reporter assays. Cell proliferation was examined via CCK-8 and clone formation assays. The expression levels of the related proteins were measured via Western blotting. Autophagosomes were observed under transmission electron microscopy. Lentiviral vectors carrying Atg7/UVRAG shRNA or the Beclin1 gene were used to modulate the expression levels of the indicated genes. Immunofluorescence were performed to examine colocalization of BCR/ABL and p62/SQSTM1. CD34(+)CD38(-) cells were isolated from bone marrow samples from CML patients via fluorescence-activated cell sorting. Results: In this study, we observed that Beclin1 directly interacts with BCR/ABL. Beclin1 inhibited the activity of the BCR/ABL promoter to downregulate the level of BCR/ABL protein and to promote the downstream colocalization of p62/SQSTM1 and BCR/ABL to autolysosomes for degradation via activation of the autophagy signaling pathway. In CML cell lines, primary cells and CD34(+)CD38(-) leukemia stem cells, Beclin1 overexpression significantly inhibited cell growth and proliferation and induced autophagy. Conclusion: Taken together, our results suggest that autophagy induction via Beclin1 overexpression might offer new approaches for treating TKI-resistant CML and for promoting the clearance of leukemia stem cells, both of which have important clinical implications.

BECN2 (beclin 2)-mediated non-canonical autophagy in innate immune signaling and tumor development

Beclin 2 negatively regulates innate immune signaling and tumor development

BECN2 (beclin 2) Negatively Regulates Inflammasome Sensors Through ATG9A-Dependent but ATG16L1- and LC3-Independent Non-Canonical Autophagy

AMPK Regulates Autophagy by Phosphorylating BECN1 at Threonine 388.

CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression

Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity

1897-P: BECN1, a Key Autophagy Protein, Regulates Adiponectin Secretion in Adipocytes by Interacting with the Exocyst Components

Divergent Roles of BECN1 in LC3 Lipidation and Autophagosomal Function.

Beclin-1: autophagic regulator and therapeutic target in cancer.

BECN1/Beclin 1 sorts cell-surface APP/amyloid β precursor protein for lysosomal degradation

BECN1s, a Short Splice Variant of BECN1, Functions in Mitophagy.

Identification of Barkor As a Mammalian Autophagy-Specific Factor for Beclin 1 and Class III Phosphatidylinositol 3-Kinase.

Regulation of autophagy by E3 ubiquitin ligase RNF216 through BECN1 ubiquitination

A Non-canonical MEK/ERK Signaling Pathway Regulates Autophagy Via Regulating Beclin 1*

The autophagy-independent role of BECN1 in colorectal cancer metastasis through regulating STAT3 signaling pathway activation

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy.

Beclin 1 Phosphorylation - at the Center of Autophagy Regulation

The Function of Bcl-2/Beclin-1 Complex in Autophagy Regulation

Myeloid Loss of Beclin 1 Promotes PD-L1hiprecursor B Cell Lymphoma Development.

IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation

Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon